BCAB
BioAtla, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Jay Short
IPO Date
2020-12-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
BioAtla, Inc.
CEO
Jay Short
IPO Date
2020-12-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 430,000 |
| $0.00 |
| 12 Mar 2026 | Vasquez Christian | Chief Financial Officer | A-Award | Acquired | 240,000 | $0.00 |
| 2 Mar 2026 | SHORT JAY M PHD | director, officer: Chief Executive Officer | F-InKind | Disposed | 7,728 | $0.25 |
| 2 Mar 2026 | Vasquez Christian | Chief Financial Officer | F-InKind | Disposed | 1,802 | $0.25 |
| 2 Mar 2026 | WALDRON RICHARD A | Former Chief Financial Officer | F-InKind | Disposed | 2,729 | $0.25 |
| 2 Mar 2026 | Sievers Eric | Chief Medical Officer | F-InKind | Disposed | 3,140 | $0.25 |
| 1 Dec 2025 | WALDRON RICHARD A | Chief Financial Officer | F-InKind | Disposed | 2,371 | $0.90 |
| 1 Dec 2025 | Sievers Eric | Chief Medical Officer | F-InKind | Disposed | 2,729 | $0.90 |
| 1 Dec 2025 | SHORT JAY M PHD | director, 10 percent owner, officer: Chief Executive Officer | F-InKind | Disposed | 6,347 | $0.90 |